Sterling Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,951
Closed -$2.05M 61
2024
Q1
$2.05M Buy
3,951
+3
+0.1% +$1.49K 1.44% 25
2023
Q4
$1.86M Sell
3,948
-92
-2% -$42.5K 1.37% 27
2023
Q3
$1.76M Sell
4,040
-68
-2% -$30.8K 1.56% 24
2023
Q2
$1.83M Sell
4,108
-56
-1% -$25.8K 1.45% 23
2023
Q1
$1.91M Sell
4,164
-56
-1% -$26.6K 1.52% 19
2022
Q4
$2.16M Sell
4,220
-269
-6% -$137K 1.74% 18
2022
Q3
$2.04M Buy
4,489
+627
+16% +$300K 1.72% 17
2022
Q2
$1.86M Buy
3,862
+513
+15% +$254K 1.55% 18
2022
Q1
$1.65M Sell
3,349
-686
-17% -$314K 1.16% 26
2021
Q4
$1.87M Sell
4,035
-53
-1% -$22.3K 1.16% 29
2021
Q3
$1.52M Buy
4,088
+69
+2% +$26.2K 0.97% 36
2021
Q2
$1.53M Sell
4,019
-1,884
-32% -$720K 1.01% 32
2021
Q1
$2.12M Sell
5,903
-331
-5% -$106K 1.45% 25
2020
Q4
$2M Buy
6,234
+71
+1% +$21.8K 1.42% 26
2020
Q3
$1.66M Sell
6,163
-457
-7% -$123K 1.24% 26
2020
Q2
$1.74M Sell
6,620
-1,917
-22% -$511K 1.35% 25
2020
Q1
$1.94M Buy
8,537
+6,493
+318% +$1.77M 1.69% 18
2019
Q4
$617K Buy
2,044
+7
+0.3% +$1.93K 0.41% 49
2019
Q3
$489K Sell
2,037
-6,578
-76% -$1.8M 0.36% 46
2019
Q2
$2.43M Sell
8,615
-251
-3% -$68.6K 1.88% 17
2019
Q1
$2.54M Sell
8,866
-5,058
-36% -$1.46M 1.97% 16
2018
Q4
$3.66M Sell
13,924
-565
-4% -$155K 3.06% 9
2018
Q3
$3.97M Sell
14,489
-136
-0.9% -$35.3K 2.88% 11
2018
Q2
$3.48M Buy
14,625
+892
+6% +$207K 2.7% 10
2018
Q1
$3.02M Buy
13,733
+3,021
+28% +$710K 2.44% 12
2017
Q4
$2.41M Buy
10,712
+854
+9% +$182K 2.57% 11
2017
Q3
$1.87M Sell
9,858
-546
-5% -$104K 2.54% 14
2017
Q2
$1.96M Sell
10,404
-79
-0.8% -$14.2K 2.58% 14
2017
Q1
$1.73M Sell
10,483
-593
-5% -$94.3K 2.43% 16
2016
Q4
$1.59M Sell
11,076
-364
-3% -$48.7K 2.27% 18
2016
Q3
$1.43M Sell
11,440
-19
-0.2% -$2.45K 2.1% 20
2016
Q2
$1.5M Sell
11,459
-480
-4% -$65.7K 2.06% 21
2016
Q1
$1.66M Sell
11,939
-6,481
-35% -$866K 2.26% 18
2015
Q4
$2.57M Sell
18,420
-1,800
-9% -$248K 2.22% 18
2015
Q3
$2.83M Sell
20,220
-238
-1% -$35.8K 2.23% 15
2015
Q2
$3.36M Sell
20,458
-1,166
-5% -$186K 2.53% 12
2015
Q1
$3.34M Sell
21,624
-1,350
-6% -$192K 2.36% 13
2014
Q4
$2.89M Sell
22,974
-1,590
-6% -$196K 1.99% 20
2014
Q3
$2.94M Sell
24,564
-121
-0.5% -$13.9K 2.06% 17
2014
Q2
$2.66M Sell
24,685
-475
-2% -$48.9K 1.87% 19
2014
Q1
$2.5M Sell
25,160
-40
-0.2% -$3.62K 1.84% 22
2013
Q4
$2.33M Sell
25,200
-215
-0.8% -$19.1K 1.68% 23
2013
Q3
$2.13M Sell
25,415
-130
-0.5% -$11.1K 1.49% 28
2013
Q2
$2.09M Buy
+25,545
New +$1.91M 1.48% 29

Other funds holding ELV

Sterling Investment Management's ELV Position: Q2 2024 in Review

Sterling Investment Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 3,951 shares — an estimated $2.05M sold.

Sterling Investment Management first reported a position in ELV in Q2 2013 and held it in 44 quarters. The position peaked at $3.97M in Q3 2018. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Sterling Investment Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Sterling Investment Management sold 3,951 Elevance Health shares in Q2 2024, an estimated $2.05M.
  • Sterling Investment Management first reported a position in Elevance Health in Q2 2013 and held it in 44 quarters.
  • Sterling Investment Management's Elevance Health position peaked at $3.97M in Q3 2018.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Sterling Investment Management's 13F filing for Q2 2024, filed 26 Jul 2024.